Physician profile
Gregory Climaco
NPI 1316034143
$18,597.17
in general payments reported to CMS, 2019-2025
49 companies · $3,122 in 2025
The $3,122 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,870 · 2020: $2,283 · 2021: $3,341 · 2022: $2,006 · 2023: $2,105 · 2024: $2,871 · 2025: $3,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,059 · Education: $38.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,058.91 |
| Education | $38.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $3,366.23 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $3,112.14 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $2,044.46 | 2019-2025 | Qulipta, Ubrelvy, Vraylar |
| Lilly USA, LLC | $1,458.97 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Janssen Pharmaceuticals, INC | $1,308.66 | 2019-2025 | Spravato |
| Pfizer INC. | $812.92 | 2020-2025 | |
| Amgen INC. | $790.88 | 2019-2025 | Evenity, Prolia, Otezla |
| Allergan, INC. | $775.42 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $652.00 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Glaxosmithkline, LLC. | $521.27 | 2019-2024 | Arexvy, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $436.77 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $339.61 | 2019-2025 | Austedo Xr, Austedo Xr |
| Axsome Therapeutics, INC. | $232.99 | 2024-2025 | Auvelity, Symbravo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $216.56 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $208.39 | 2021 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Climaco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.